The hyperglycemic hyperosmolar syndrome.
D000138:Acidosis / Q000150:complications; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000818:Animals; D000941:Antigens; D000959:Antihypertensive Agents / Q000009:adverse effects; D001786:Blood Glucose / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000502:physiology; D004573:Electrolytes / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000628:therapy*; D007263:Infusions, Parenteral; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D007657:Ketone Bodies / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D009994:Osmolar Concentration; D014474:Unconsciousness / Q000209:etiology
D000305:Adrenal Cortex Hormones; D000941:Antigens; D000959:Antihypertensive Agents; D001786:Blood Glucose; D004573:Electrolytes; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007657:Ketone Bodies; D008055:Lipids; D005947:Glucose